# The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome

> **NCT00518960** · NA · UNKNOWN · sponsor: **Health Enhancement Products, Inc.** · enrollment: 28 (actual)

## Conditions studied

- Metabolic Syndrome
- Hyperlipidemia

## Interventions

- **DRUG:** ProAlgaZyme

## Key facts

- **NCT ID:** NCT00518960
- **Lead sponsor:** Health Enhancement Products, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2007-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518960, "The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00518960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*